A retrospective study sought to confirm real-world outcomes of patients with HER2+ breast cancer treated with trastuzumab deruxtecan.

For local and regional tumors, redlining associations were largest in 1995 to 1999 and attenuated over time. HealthDay News — Associations between historical redlining and breast cancer survival have ...

Researchers sought to identify pain trajectories that could help clinicians individualize post-VATS pain management strategies for patients with pulmonary nodules.

Researchers conducted a literature review to better understand challenges faced by LGB patients with CRC after surgical ...

In this study, researchers aimed to examine trends in nonsurgical management and other treatment modalities in low-risk, ...

Researchers assessed the global burden and temporal trends of early-onset GI cancers, from 1990 to 2021 using data from the Global Burden of Disease 2021 study.

A qualitative study explored the value of specialized cancer nurses for patients with CRC in a country with geographic barriers to support services.

Rybrevant Faspro is a subcutaneous co-formulation of amivantamab, a bispecific EGFR-directed and MET receptor-directed antibody, and hyaluronidase.

International variation in overall survival linked to differences in childhood tumor stage distribution for some cancer types and regions.

The mechanism by which GnRH agonists may increase the short-term risk of cardiovascular events more so than other forms of testosterone suppression has been unclear.

Researchers explored the link between medication adherence and symptom distress in patients with breast cancer undergoing endocrine therapy.

Researchers evaluated the association between the use of various hormonal contraceptives and the risk for surgically treated intracranial meningioma.